Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease.

ABSTRACT:

SUBMITTER: Davidson MH 

PROVIDER: S-EPMC12811769 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature